“…With regard to ON, it has been reported that ON, due to their polyanionic nature, poorly permeate the cells to reach their intracellular target sites (17,42). Several research groups (3,29,33,40) also observed that in the absence of appropriate delivery systems, ON exhibited weak or no biological activity, whereas in the presence of delivery systems, e.g., liposomes, ON showed strong activity. In agreement with these findings, our results showed that coadministration of the ON with the liposomal agent DOTAP greatly enhanced the inhibitory activities of ON.…”